PYRIDOSTIGMINE BROMIDE

Growth

pyridostigmine bromide

NDAORALTABLET, EXTENDED RELEASE

Approved

Oct 2024

Lifecycle

Growth

Competitive Pressure

0/100

Loss of Exclusivity

LOE Date

Jun 18, 2038

149 months away

Patent Expiry

Jun 18, 2038

Patent Records (5)

Patent #	Expiry	Type	Use Code
10881617	Jun 18, 2038	Product	—
10925833	Jun 18, 2038	Product	—
10987311	Jun 18, 2038	Product	—
11229606	Jun 18, 2038	Product	—
11478425	Jun 18, 2038	Product	U-4012

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers